06078 HYGEIA HEALTH
- 37.100
- +0.400+1.09%
HYGEIA HEALTH News
海吉亞醫療：年報2023
China Post Securities: Endogenous growth is steady, and the Hong Kong stock healthcare services sector's valuation is highly attractive
Judging from the overall performance of medical service targets in Hong Kong stocks, with the exception of ICL's high revenue base in the early COVID-19 period, where dental revenue was affected by dental implant collection, most of the revenue from other medical service targets increased relatively well.
Hygea Healthcare (06078.HK) received 440,200 additional shares from Chairman and Executive Director Zhu Yiwen
Gelonghui, April 8 | According to the latest equity disclosure data of the Stock Exchange, on April 3, 2024, Hygea Healthcare (06078.HK) was granted an increase of 4402,000 shares at an average price of HK$29.54 per share on the market, involving approximately HK$13.35 million. After the increase in holdings, Zhu Yiwen's latest shareholding was 283,560,615 shares, and the shareholding ratio increased from 44.83% to 44.90%.
Hygea Healthcare received the 11th increase in shares by the controlling shareholder
Glonghui, April 5 | According to information disclosed by the Stock Exchange, on April 2 and April 3, Hygea Healthcare (6078.HK) received another increase in its holdings by Mr. Zhu Yiwen, the founder, controlling shareholder, chairman of the board of directors and CEO of the company, increasing its total holdings by about 460,000 shares. Since the company went public, Mr. Zhu Yiwen has increased his holdings of the company's shares in the secondary market 11 times. He has never reduced his holdings of the company's shares. He stands firmly with small and medium shareholders, and is full of confidence in the company's future development.
Hygea Healthcare (06078.HK) received 440,200 additional shares of common stock by Zhu Yiwen, worth approximately HK$13.35 million
On April 5, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 5, Zhu Yiwen increased her common share holdings of $Hygea Healthcare (06078.HK) by $440,200 at an average price of HK$29.54 per share on April 3, worth approximately HK$13.35 million. After the increase in holdings, Zhu Yiwen's latest shareholding was 284 million shares, and the good position ratio increased from 44.83% to 44.90%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their share interests in listed companies. upon
Hygea Healthcare (06078.HK) was granted an increase of 18,400 shares of common stock by Zhu Yiwen, worth approximately HK$547,400
On April 5, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 5, Zhu Yiwen increased her common stock holdings of $Hygea Healthcare (06078.HK) by $18.4 million at an average price of HK$29.75 per share on April 2, worth about HK$547,400. After the increase in holdings, Zhu Yiwen's latest shareholding was 283 million shares, with a good position ratio of 44.83%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their share interests in listed companies. Director and chief executive of a listed company
Hygea Healthcare (6078.HK): Performance is in line with expectations, and bed expansion is progressing steadily
Guide to this report: Performance is in line with expectations, merger and acquisition integration capabilities continue to be verified, phase II and new hospital projects are progressing steadily, and the number of beds continues to expand. It is expected that steady and rapid growth will continue and maintain an increase rating. Summary: The performance is in line with expectations, and the rating for increasing holdings is maintained
Hygea Healthcare (6078.HK): Strong management resilience and gradual entry into the harvest period
Incident On March 26, 2024, the company released its 2023 annual report. In 2023, the company achieved operating income of 4,077 billion yuan, +27.6% year-on-year, and achieved net profit of 685 million yuan to mother, year-on-year +
GF Securities: Target price of HK$38.81 for a “buy” rating for Hygea Healthcare (06078)
Zhitong Finance App learned that Guangfa Securities released a research report stating that according to the “buy” rating of Haijia Healthcare (06078), the net profit for 2024-26 is expected to be 9.0/11.4/1.43 billion yuan, respectively. Considering the scarcity of the company's private oncology medical services and the steady expansion of the business scale, the company was given a 24-year NongAAP net profit of 25x PE, with a corresponding reasonable value of HK$38.81 per share. The main points of the report are as follows: Hygea Healthcare announced 2023 full-year results. In 2023, the company achieved revenue of 4,077 billion yuan, +2 compared to the previous year
Hygea Healthcare (6078.HK) 2023 performance review: Successful hospital acquisition and integration, optimistic about 24-year performance growth
Event: The company announced its 2023 results: the company achieved revenue of 4,077 billion yuan (+27.6% YOY), net profit of 685 million yuan (+42.1% YOY), and adjusted net profit (excluding share expenses)
Hygeia Healthcare Holdings Co., Limited Just Missed Earnings - But Analysts Have Updated Their Models
As you might know, Hygeia Healthcare Holdings Co., Limited (HKG:6078) last week released its latest yearly, and things did not turn out so great for shareholders. Results look to have been somewh
Hygea (6078.HK): The release of bed capacity due to mergers and acquisitions of high-quality hospitals is expected to accelerate
Review performance grew steadily, and profit margins declined due to nucleic acid testing base, bed expansion, and mergers and acquisitions. In 2023, the company achieved revenue of 4,077 billion yuan (+27.6%) and net profit of 685 million yuan (+42.1%)
Hygea Healthcare (06078.HK): Merger and acquisition integration benefits highlight regional advantages and further strengthen brand influence
Key investment events: The company announced that in 2023, the company achieved total operating revenue of 4,084 billion yuan (+27.39%, indicating year-on-year growth rate, same below), net profit of 685 million yuan (+42.14%); adjusted net
Hygea Healthcare (6078.HK): FY23 meets expectations FY24 endogenous epitaxial drives high growth, and the operating conditions of the new hospital continue to improve
FY23's performance is in line with expectations, maintaining the 2024 adjusted net profit growth rate guide: 2023 revenue increased 27.6% year-on-year (+34.0% after excluding the impact of nucleic acid testing), net profit/adjusted net profit +42.
Hygea Healthcare (06078.HK) Hong Kong Stock Company Information Update Report: Rapid Performance Growth in 2023, Endogenous and External Growth Continues to Advance
The 2023 performance grew rapidly, and endogenous and extrinsic growth continued. Maintaining the “buy” rating, the company achieved revenue of 4,077 billion yuan in 2023 (+27.6%, excluding the impact of COVID-19, a 34% year-on-year increase), and adjusted net profit
Hygea Healthcare (6078.HK): Endogenous growth combined with epitaxial expansion will maintain rapid growth in revenue
Rapid revenue and profit growth in 2023 The company's revenue in 2023 increased 27.6% year on year to 4.08 billion yuan (RMB, same below), of which revenue after excluding the one-time impact of nucleic acid testing increased 34.0% year on year. incorporation
Hygea Healthcare (06078.HK): Acquisition of hospitals increased significantly, and 2024 results can be expected
The 2023 results are in line with our expectations Hygea Healthcare announced 2023 results: revenue of 4,077 billion yuan, +27.6% YoY (+34.0% YoY after excluding the one-time impact of nucleic acid testing); adjusted net profit 7.
Hygeia Healthcare's 2023 Profit Rises 42% on Higher Revenue; Shares Surge 15%
Hygeia Healthcare Holdings' (HKG:6078) net profit rose 42.1% to 684.9 million yuan in 2023 from 481.9 million yuan in 2022, according to a Tuesday filing with the Hong Kong bourse. The hospital operat
Hong Kong stock changes丨Hygea Healthcare rose more than 17%. Last year's net profit increased 42% year on year to 685 million yuan
Glonghui March 27 | Hygea Healthcare (6078.HK) rose sharply by more than 17% during the intraday period, and its stock price returned to the HK$30 mark, with a total market value of HK$18.8 billion. According to the news, the company announced last night that the Group achieved revenue of 4,077 billion yuan (same unit) in 2023, up 27.57% year on year; net profit of 685 million yuan, up 42.14% year on year; adjusted net profit of 713 million yuan, 17.53% year on year; and basic profit of 1.08 yuan per share. Guojin Securities reviews that the hospital business is growing healthily, self-built mergers and acquisitions continue to advance, maintaining a “buy” rating.
Changes in Hong Kong stocks | Hygea Healthcare (06078) rose more than 11%, and adjusted net profit increased 17.53% year-on-year last year, and the hospital business continued to grow healthily
Hygea Healthcare (06078) rose more than 11%. As of press release, it rose 10.46% to HK$29.05, with a turnover of HK$44.1561 million.
Analysis
Price Target
No Data
